Mohamed Elgendy

Dr. Mohamed Elgendy

orcid
University Hospital Dresden

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2021 in Autophagy
Verified
Journal Article
Closed access
DKDaniel J. Klionsky
Daniel J. Klionsky
AAAmal Kamal Abdel-Aziz
Amal Kamal Abdel-Aziz
SASara Abdelfatah
Sara Abdelfatah
MAMahmoud Abdellatif
Mahmoud Abdellatif
AAAsghar Abdoli
Asghar Abdoli
CTChun-Kit Tong
Chun-Kit Tong

1 April 2011 in Molecular Cell
Verified
Journal Article
Closed access
Mohamed ElgendyMohamed Elgendy
Mohamed Elgendy
CSClare Sheridan
Clare Sheridan
GBGabriela Brumatti
Gabriela Brumatti
SMSeamus J. Martin
Seamus J. Martin

1 May 2019 in Cancer Cell
Verified
Journal Article
Closed access
Mohamed ElgendyMohamed Elgendy
Mohamed Elgendy
MCMarco Cirò
Marco Cirò
AHAmir Hosseini
Amir Hosseini
JWJakob Weiszmann
Jakob Weiszmann
Luca MazzarellaLuca Mazzarella
Luca Mazzarella
SMSaverio Minucci
Saverio Minucci

3 September 2009 in Nature Protocols
Verified
Journal Article
Closed access
SLSusan E. Logue
Susan E. Logue
Mohamed ElgendyMohamed Elgendy
Mohamed Elgendy
SMSeamus J Martin
Seamus J Martin

1 June 2014 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
Amal Kamal Abdel-AzizAmal Kamal Abdel-Aziz
Amal Kamal Abdel-Aziz
SSsamia shouman
samia shouman
EEEbtehal El-Demerdash
Ebtehal El-Demerdash
Mohamed ElgendyMohamed Elgendy
Mohamed Elgendy
AAAshraf B. Abdel-Naim
Ashraf B. Abdel-Naim

4 December 2014 in Nature Communications
Verified
Journal Article
Open access
PDF file
Mohamed ElgendyMohamed Elgendy
Mohamed Elgendy
MCMarco Ciro
Marco Ciro
Amal Kamal Abdel-AzizAmal Kamal Abdel-Aziz
Amal Kamal Abdel-Aziz
GBGiuseppe Belmonte
Giuseppe Belmonte
RZRoberto Dal Zuffo
Roberto Dal Zuffo
SMSaverio Minucci
Saverio Minucci
Mcl-1 is a unique Bcl-2 family member that plays crucial roles in apoptosis. Apoptosis-unrelated functions of Mcl-1 are however emerging, further justifying its tight regulation. Here we unravel a novel mechanism of Mcl-1 regulation mediated by the haplo-insufficient tumour suppressor Beclin 1. Beclin 1 negatively modulates Mcl-1 stability in a reciprocal manner whereby depletion of one leads to the stabilization of the other. This co-regulation is independent of autophagy and of their physical interaction. Both Beclin 1 and Mcl-1 are deubiquitinated and thus stabilized by binding to a common deubiquitinase, USP9X. Beclin 1 and Mcl-1 negatively modulate the proteasomal degradation of each other through competitive displacement of USP9X. The analysis of patient-derived melanoma cells and tissue samples shows that the levels of Beclin 1 decrease, while Mcl-1 levels subsequently increase during melanoma progression in a significant inter-dependent manner. The identified inverse co-regulation of Beclin 1 and Mcl-1 represents a mechanism of functional counteraction in cancer.